{"id":7649,"date":"2022-06-30T11:36:13","date_gmt":"2022-06-30T09:36:13","guid":{"rendered":"https:\/\/test.lab.cor2ed.com\/cms\/?post_type=experts&#038;p=7649"},"modified":"2023-06-14T09:39:32","modified_gmt":"2023-06-14T07:39:32","slug":"dr-philipp-ivanyi","status":"publish","type":"experts","link":"https:\/\/test.lab.cor2ed.com\/cms\/experts\/dr-philipp-ivanyi\/","title":{"rendered":"Dr Philipp Ivanyi"},"content":{"rendered":"<p>Dr Ivanyi is the Assistant Medical Director Hematology, Oncology, Hemostasis, Stem Cell Transplantation (Palliative Care) at the Hanover Medical School. He is also Head of the Clinical Trial Unit for Medical Oncology<\/p>\n<p>Dr Ivanyi also serves as:<\/p>\n<ul>\n<li>Steering Committee and Spokesman, Immune Cooperative Oncology Group, Comporehensive Cancer Center, Claudia von Schelling Center (CCC-H)<\/li>\n<li>Board Member, Clinical Trial Steering Committee, CCC-H<\/li>\n<li>Spokesman Interdisciplinary Working Group Kidney Cancer, Germany Cancer Society (IAGN-DKG)<\/li>\n<\/ul>\n<p>His research interests include clinical and experimental Research in Urogenital Cancer, Head and Neck Cancer, Sarcoma, Rare Cancers, Targeted Therapies. He has &gt;80 SCI Publication and has a depth of experience in &gt;50 Clinical Trials Phase I \u2013 IV (PI and Country Lead).<\/p>\n","protected":false},"author":{"id":36,"first_name":"Iain","last_name":"Murdoch","nickname":"iain.murdoch@cor2ed.com","email":"iain.murdoch@cor2ed.com"},"featured_media":7650,"menu_order":15,"template":"","groups":[24],"class_list":["post-7649","experts","type-experts","status-publish","has-post-thumbnail","hentry","groups-members"],"expert_info_prefix":"Dr","expert_info_first-name":"Philipp","expert_info_last-name":"Ivanyi","expert_info_institution":"Hannover Medical School","expert_info_country":"DE","expert_info_specialization":"Medical Oncologist","expert_info_map-code":"eu_53","expert_info_disclosures":"<p>AIM, AIO, Apogepha, Astella, Astra Zeneca, Bayer, BMS, ClinSol, Deciphera, Deutsche Gesellschaft f\u00fcr Thoraxchirurgie, DKG-Onkoweb, EISAI, EMD-Serono, EUSA, FoFM, GSK, Id-Institut, Ipsen (Europe), Lilly, MedKom, Metaplan, MedWiss, Merck Serono (Global), MSD, MTE-Academy, New Concept Oncology, Nieders\u00e4chsische Krebsgesellschaft, Novartis, Onkowissen-tv.de, Pharma Mare, Pfizer, Roche, Schmitz-Communikation, Solution Academy,Stiftung Immunonkologie, StreamedUP!,\u00a0ThinkWired!, Vivantis and Wilhelm Sander Stiftung.<\/p>","expert_info_linkedin":"","expert_info_twitter":"","expert_info_instagram":"","expert_info_facebook":"","_links":{"self":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/7649","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts"}],"about":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/types\/experts"}],"version-history":[{"count":2,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/7649\/revisions"}],"predecessor-version":[{"id":88308,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/experts\/7649\/revisions\/88308"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media\/7650"}],"wp:attachment":[{"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/media?parent=7649"}],"wp:term":[{"taxonomy":"groups","embeddable":true,"href":"https:\/\/test.lab.cor2ed.com\/cms\/wp-json\/wp\/v2\/groups?post=7649"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}